"To Be Announced in Early 2023!"
Thank you all who submitted stories this year! ID pharmacists have been making a huge impact in antimicrobial deprescribing in patients with COVID-19 through interventions and identifying trends! Please check out the top five stories below!
Congratulations to our TWO grand prize winners, Aleena Issac & Tatiana Marins! Each of them will receive a free one-year SIDP membership.
Dr. Aleena Issac, PharmD: “Story of an observer clinical pharmacist who once struggled with de-prescribing unindicated antibiotics to an empowered clinical pharmacist who confidentially did evidence-based de-prescription with the support of a mandatory Government treatment directive.”
Dr. Tatiana Marins, PharmD: “I am a clinical pharmacist in Brazil and I have 15 years of experience and I´m very excited about how we pharmacists can impact the rational use of medicines and contribute to patient safety! I´ve always enjoyed studying antimicrobials and during the pandemic the challenges encountered made me seek more knowledge on the subject!”
We also selected three additional winners to receive SIDP water bottles. These stories were submitted by Stephanie May, Ryan Stevens, and Hunter Rondeau.
Dr. Stephanie May, PharmD (@stephshealymay): “ID/ASP Telehealth Pharmacists implemented a multi-faceted intervention to address unnecessary antibiotic use in COVID-19 patients across 18 community hospitals. The intervention resulted in a 50% reduction in antibiotic use for COVID and an estimated >3k antibiotic days avoided.”
Dr. Ryan Stevens, PharmD (@Stevens_AK): “Our ASP team responded quickly to this need by building ASP alerts for patients w/ COVID-19 on abx for respiratory indications. These alerts continue to help maintain ASP focus on this issue as patient volumes continue to change, and has helped keep rates of antibiotic use low.”
Learn more here: https://academic.oup.com/jacamr/article/3/4/dlab170/6420893
Dr. Hunter Rondeau, PharmD (@Floralquinolone): “With mentorship from @IDPharmD_Kate and inspiration from @ErinMcCreary, the development of a simple one-line statement in the EHR helped drastically reduce the amount of vancomycin prescribing in a newly converted, overflow MICU for COVID-19 patients.”